Wall Street expects a year-over-year decline in earnings on higher revenues when CMS Energy (CMS - Free Report) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 28. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis energy company is expected to post quarterly earnings of $0.63 per share in its upcoming report, which represents a year-over-year change of -11.3%.
Revenues are expected to be $1.95 billion, up 6.2% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 6.1% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for CMS Energy?For CMS Energy, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -10.40%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that CMS Energy will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that CMS Energy would post earnings of $1.11 per share when it actually produced earnings of $1.13, delivering a surprise of +1.80%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
CMS Energy doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerNextEra Energy (NEE - Free Report) , another stock in the Zacks Utility - Electric Power industry, is expected to report earnings per share of $1.08 for the quarter ended June 2026. This estimate points to a year-over-year change of +2.9%. Revenues for the quarter are expected to be $7.97 billion, up 18.9% from the year-ago quarter.
The consensus EPS estimate for NextEra has been revised 5% higher over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -0.47%.
This Earnings ESP, combined with its Zacks Rank #2 (Buy), makes it difficult to conclusively predict that NextEra will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
California Public Employees Retirement System lowered its position in CMS Energy Corporation (NYSE:CMS – Free Report) by 16.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 633,281 shares of the utilities provider’s stock after selling 128,881 shares during the quarter. California Public Employees Retirement System owned 0.20% of CMS Energy worth $49,130,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. Sound Income Strategies LLC raised its holdings in shares of CMS Energy by 84.4% in the 4th quarter. Sound Income Strategies LLC now owns 343 shares of the utilities provider’s stock worth $25,000 after purchasing an additional 157 shares during the period. Elyxium Wealth LLC purchased a new stake in shares of CMS Energy during the 4th quarter worth about $29,000. DV Equities LLC purchased a new stake in shares of CMS Energy during the 4th quarter worth about $29,000. MidFirst Bank acquired a new stake in CMS Energy during the 4th quarter worth approximately $31,000. Finally, Quest 10 Wealth Builders Inc. increased its position in CMS Energy by 653.2% during the 4th quarter. Quest 10 Wealth Builders Inc. now owns 467 shares of the utilities provider’s stock worth $33,000 after purchasing an additional 405 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Insider Activity at CMS Energy In related news, SVP Brandon J. Hofmeister sold 3,000 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $74.31, for a total value of $222,930.00. Following the transaction, the senior vice president owned 67,111 shares in the company, valued at approximately $4,987,018.41. The trade was a 4.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.50% of the company’s stock.
Analysts Set New Price Targets Several research analysts recently commented on CMS shares. Barclays raised their price target on shares of CMS Energy from $79.00 to $81.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Weiss Ratings reissued a “buy (b)” rating on shares of CMS Energy in a research report on Friday, June 5th. Morgan Stanley set a $77.00 target price on shares of CMS Energy in a research note on Thursday, May 21st. Wall Street Zen upgraded shares of CMS Energy from a “strong sell” rating to a “sell” rating in a report on Sunday, July 5th. Finally, Truist Financial reduced their target price on shares of CMS Energy from $86.00 to $83.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Seven analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, CMS Energy currently has a consensus rating of “Moderate Buy” and a consensus target price of $81.33.
View Our Latest Research Report on CMS Energy
CMS Energy Stock Performance CMS Energy stock opened at $72.88 on Tuesday. CMS Energy Corporation has a 12-month low of $68.64 and a 12-month high of $80.36. The company has a market capitalization of $22.51 billion, a price-to-earnings ratio of 20.13, a price-to-earnings-growth ratio of 2.67 and a beta of 0.35. The company has a debt-to-equity ratio of 1.80, a current ratio of 0.84 and a quick ratio of 0.66. The firm’s fifty day moving average price is $74.13 and its 200 day moving average price is $74.62.
CMS Energy (NYSE:CMS – Get Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The utilities provider reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.02. The company had revenue of $2.73 billion during the quarter, compared to analysts’ expectations of $2.46 billion. CMS Energy had a net margin of 12.55% and a return on equity of 12.17%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.02 EPS. CMS Energy has set its FY 2026 guidance at 3.830-3.90 EPS. On average, research analysts forecast that CMS Energy Corporation will post 3.87 EPS for the current fiscal year.
About CMS Energy (Free Report)
CMS Energy (NYSE: CMS) is an energy company based in Jackson, Michigan, whose principal business is the regulated utility operations of its subsidiary, Consumers Energy. The company is primarily focused on providing electric and natural gas service to customers in Michigan, operating the generation, transmission and distribution infrastructure necessary to deliver energy to residential, commercial and industrial customers. Headquartered in Jackson, CMS Energy conducts its core activities within the state and is regulated by state utility authorities.
Through Consumers Energy and related subsidiaries, CMS Energy develops, owns and operates a portfolio of generation assets and delivers a range of customer-facing services, including electricity and natural gas supply, grid management, energy efficiency programs and demand-response offerings.
Recommended Stories Five stocks we like better than CMS Energy The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for CMS Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CMS Energy and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECalifornia Public Employees Retirement System Grows Stock Holdings in United Therapeutics Corporation $UTHR
NEXT HEADLINE »Dollar General Corporation $DG Shares Sold by California Public Employees Retirement System
Resources Investor Relations Journalists Agencies Client Login Send a Release
News Products Contact Hamburger menu Send a Release
JACKSON, Mich., July 20, 2026 /PRNewswire/ -- The Board of Directors of CMS Energy has declared a quarterly dividend on the company's common stock.
The dividend for the common stock (CUSIP: 125896100) is 57 cents per share. It is payable Sept. 1, 2026, to shareholders of record on Aug. 7, 2026.
Additional dividend information, including the tax status of CMS Energy's dividend distributions, can be obtained through the Tax Information section of CMS Energy's website, www.cmsenergy.com.
CMS Energy (NYSE: CMS) is a Michigan-based energy company featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
For more information on CMS Energy, please visit our website at cmsenergy.com.
To sign up for email alert notifications, please visit the Investor Relations section of our website.
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? CMS Energy (CMS - Free Report) , which belongs to the Zacks Utility - Electric Power industry, could be a great candidate to consider.
When looking at the last two reports, this energy company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 1.43%, on average, in the last two quarters.
For the last reported quarter, CMS Energy came out with earnings of $1.13 per share versus the Zacks Consensus Estimate of $1.11 per share, representing a surprise of 1.80%. For the previous quarter, the company was expected to post earnings of $0.94 per share and it actually produced earnings of $0.95 per share, delivering a surprise of 1.06%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for CMS Energy lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
CMS Energy currently has an Earnings ESP of +6.57%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 28, 2026.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
CMS Energy (CMS) is reaffirmed as a Buy, supported by a $24 billion five-year capex plan driving robust rate base and EPS growth. CMS targets 6–8% annual adjusted EPS growth, with consensus estimates at the high end, and maintains a stable BBB credit rating. Shares trade at a modest 3% discount to fair value, with potential for 9%+ annual total returns through 2031, underpinned by disciplined capital deployment.
, /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, today announced an additional AI‑empowered drug discovery collaboration targeting a mass-market indication in central nervous system with an innovative mechanism of action (MoA) identified by PandaOmics.
According to the collaboration agreement, the two parties will jointly advance the co-development of the R&D program by combining Insilico Medicine's validated AI platform and AI-enabled innovative drug discovery and development capabilities with CMS's experienced R&D team and deep therapeutic expertise. Insilico Medicine is eligible to receive up to approximately 1.2 billion RMB in milestone payments plus royalties. This partnership marks a deepening collaboration that leverages both parties' complementary strengths across the full value chain—from drug discovery and clinical development to commercialization.
Mr. Lam Kong, the Chairman, Chief Executive Officer, President and Executive Director of CMS said: "CMS is deeply impressed by Insilico Medicine's capability and productivity in AI drug discovery. We are happy to deepen our collaboration with Insilico Medicine. Insilico Medicine's leadership in AI drug discovery platforms and data-driven R&D is strategically complementary to CMS's capabilities in innovative R&D and clinical translation. In addition, CMS has built solid strengths in clinical development systems and efficiency, regulatory submission expertise, and commercialization network coverage. Our goal never changes: to accelerate the delivery of more clinically meaningful innovations to patients with greater speed and quality, better meeting the growing clinical needs."
"We are delighted to establish another collaboration with China Medical System just three months after our initial announcement," said Feng Ren, PhD, Co-CEO and Chief Scientific Officer of Insilico Medicine. "Our existing partnership, announced earlier this year, has been seamless and productive since its inception. In this new program, we value the input from the CMS commercialization team and are proud of the innovative Mechanism of Action (MoA) identified by PandaOmics, which streamlines the development of high-potential drugs, enhancing translational efficiency, and accelerating the transition of molecules from 'proof of concept' to life-changing patient therapies. We will continue to deepen our multi-dimensional collaboration in pipeline and clinical strategy and global partnerships to provide patients with more differentiated and accessible treatment options."
About CMS
CMS (HKEX stock code:867; SGX stock code: 8A8) is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/gastroenterology/ophthalmology/ skin health businesses, bringing economies of scale in specialty fields.
About Insilico Medicine
Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend health longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK.
By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma.AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine. For more information, please visit www.insilico.com
JACKSON, Mich., July 7, 2026 /PRNewswire/ -- CMS Energy announced today it will provide 2026 second quarter results along with a business and financial outlook at 10:00 a.m. EDT on Tuesday, July 28, 2026.
A webcast of the presentation will be available on CMS Energy's website, cmsenergy.com. An audio replay will be available approximately three hours after the webcast and will be archived for 30 days on CMS Energy's website in the "Investors" section.
CMS Energy (NYSE: CMS) is a Michigan-based energy company featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
For more information on CMS Energy, please visit our website at cmsenergy.com. To sign up for email alert notifications, please visit the Investor Relations section of our website.
, /PRNewswire/ -- CMS Energy announced today that Polly Harris has been named vice president of human resources, effective July 20.
Harris was previously with Union Pacific Railroad, where she served most recently as vice president of human resources.
She brings more than two decades of human resources experience to the table. She launched her career with John Deere, grew her expertise during three years with Conagra Brands, and has spent the last 18+ years dedicated to supporting the team at Union Pacific.
She holds a bachelor's degree from the University of Iowa and an M.B.A. from the University of Phoenix. Additionally, she completed the Advanced HR Executive Program through the Michigan Ross School of Business.
"Polly is an experienced HR executive and talent strategist with a strong background in enterprise transformation, culture, workforce engagement and HR operations," said Shaun Johnson, CMS Energy's executive vice president, chief legal & administrative officer.
"She helped lead people strategy for a large, union and salaried workforce, and her experience includes championing a holistic culture of employee well-being, driving safe and healthy operational environments, talent management, workforce planning, succession, engagement, compensation and benefits, employee relations, organizational design, and culture transformation. We are excited for her to bring her talent and experience to our company."
CMS Energy (NYSE: CMS) is a Michigan-based energy provider featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
, /PRNewswire/ -- CMS Energy announced today that Chris Shellberg has been named vice president of low-voltage electric distribution, effective July 1.
Shellberg will manage the company's low-voltage distribution (LVD) system that delivers electricity safely and reliably 24/7 to nearly 2 million homes and businesses through CMS Energy's chief subsidiary, Consumers Energy.
She has served most recently as Consumers Energy's senior executive director of LVD operations and holds a bachelor's degree in electrical and electronics engineering from Western Michigan University.
"Chris brings 30 years of experience at Consumers Energy and a strong record of operational leadership across LVD operations, fleet and facilities, meter operations and operations services," said Greg Salisbury, CMS Energy's senior vice president of electric distribution.
"She brings deep expertise in distribution, service restoration, metering, smart grid, contract negotiations and financial management. With her technical background, business knowledge and commitment to safe, reliable service, Chris is well positioned to lead our LVD team to keep the lights on for Michigan."
CMS Energy (NYSE: CMS) is a Michigan-based energy provider featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
ARLINGTON, Va., June 23, 2026 (GLOBE NEWSWIRE) -- Tria Federal today announced the appointment of Rajiv Uppal, former Chief Information Officer of the Centers for Medicare & Medicaid Services (CMS) and the Internal Revenue Service (IRS), to the company’s Advisory Board.
The Tria Advisory Board provides strategic guidance and perspective from leaders who have shaped some of the nation’s largest federal health and technology organizations, helping Tria remain responsive to evolving agency priorities and modernization challenges.
Uppal will serve alongside current Tria Advisory Board members Jennifer “Jenni” Main, former Chief Operating Officer of CMS, and Sonny Hashmi, former Commissioner of the General Services Administration’s (GSA) Federal Acquisition Service and former GSA CIO.
“We are thrilled to welcome Rajiv to the Tria Advisory Board as we help federal health agencies balance cost, quality and access to care,” said Bryce Golwalla, Tria’s Senior Vice President, Public Health. “Rajiv has directed modernization initiatives where the stakes are incredibly high and the systems impact millions of Americans. His experience across CMS and the IRS brings valuable insight into how agencies can modernize responsibly while ensuring operational continuity, security, and long-term mission outcomes.”
Uppal brings to the Advisory Board more than 30 years of experience leading enterprise technology modernization initiatives across both the public and private sectors. Most recently, he served as CIO of the IRS, where he led efforts to modernize mission-critical systems, strengthen cybersecurity, and improve taxpayer services and operational efficiency.
Prior to the IRS, Uppal served as CIO and Director of CMS’s Office of Information Technology, where he led large-scale technology transformation initiatives supporting Medicare and Medicaid systems used by millions of Americans. His experience spans cloud modernization, enterprise platform strategy, cybersecurity, operational transformation, and AI-enabled innovation across highly regulated federal environments.
“I’m honored to join the Tria Advisory Board at a time when agencies are navigating increasingly complex modernization and operational challenges,” said Uppal. “They need practical modernization that improves resilience, strengthens service delivery, and helps teams operate more effectively under real-world constraints. Tria’s ability to connect innovation with operational outcomes is what makes this opportunity especially compelling to me.”
The Tria Advisory Board was established to help guide the company’s continued growth and innovation across the federal health landscape. With decades of experience across government, healthcare, technology, operations, and enterprise modernization, Advisory Board members provide strategic insight and guidance that help Tria remain responsive to evolving agency priorities, modernization challenges, and emerging technologies.
About Tria Federal
Tria Federal builds, modernizes, and operates mission-critical federal health platforms and programs. As a health solutions company, we make federal health systems work—at scale, on time, and under pressure. We operate at the center of the healthcare trilemma, minimizing cost, improving quality, and expanding access to care in environments where failure is not an option. For two decades, federal agencies have relied on Tria to keep America’s health systems reliable, accountable, and secure. Visit www.triafed.com to learn more.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/08fb3178-c884-41fc-8381-926243643137
Tria Federal appoints Rajiv Uppal to Advisory Board Tria Federal today announced the appointment of Rajiv Uppal, former Chief Information Officer of the...
SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People’s Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.
Silevimig Injection is the world’s first fully human bispecific antibody targeting dual epitopes of the rabies virus (“RABV”), which is consistent with the recommendations of the World Health Organization (“WHO”) for a “cocktail” therapeutic paradigm. It demonstrates broad neutralization, which can effectively neutralize different viral strains or genotypes of RABV, providing immediate protection. Moreover, it is the passive immunization product with the smallest dose for rabies, resulting in less injection volume and easier administration, which can effectively reduce patient pain and improve compliance. In addition, the Product can be manufactured at scale with standardized processes and controlled production cost, and also carries no risks of blood-borne infections, low immunogenicity, and minimal interference with vaccine-induced active immunization. The market for rabies passive immunization is substantial, yet existing passive immunization products are constrained by low market penetration and limitations in safety and accessibility. The approval of the Product will provide a new treatment option for patients requiring urgent post-exposure management against rabies in China.
The approval of Silevimig Injection expands the Group’s commercialized innovative drug portfolio to 8 products, with 6 more innovative drugs under marketing review and approximately 20 projects advancing clinical development, further strengthening a tiered innovation pipeline. As of now, CMS’s innovation transformation strategy has fully entered the value-harvesting phase. Leveraging the Group’s existing expert network and market resources, the commercialization rollout of Silevimig Injection is expected to proceed steadily providing sustained momentum to the Group’s performance growth.
About Rabies
Rabies is an acute zoonotic disease caused by RABV, clinically characterized by aerophobia, hydrophobia, pharyngeal muscle spasms, and progressive paralysis[1], with a case-fatality rate approaching 100%. At present, there is no proven treatment for rabies once clinical symptoms appear. Standardized post-exposure management, comprising wound care, vaccination, and passive immunization administered as needed, remains the most effective strategy[2]. As vaccine-induced antibodies require 1-2 weeks after the first dose of vaccine injection to reach protective levels, passive immunization provides immediate coverage[1]. According to the National Technical Guidelines for the Rabies Exposure Prophylaxis (2023 Edition), patients with Category III exposure and those with Category II exposure involving severe immunodeficiency should receive passive immunization at the same time as the first dose of rabies vaccine[3]. In China, more than 40 million people are exposed to rabies annually, of whom approximately 40% fall under Category III exposure[1]. However, due to factors such as limited awareness, high cost, and restricted accessibility, only about 15% of Category III cases receive passive immunization[1]. Currently, the primary approved passive immunization option in China is human rabies immune globulin (“HRIG”). However, HRIG must be sourced from healthy donors, making it difficult and costly to obtain. Furthermore, it carries potential risks of blood-borne infections. This has led to a low penetration rate of passive immunization products in China.
More information about Silevimig Injection
Silevimig Injection is a recombinant, fully human bispecific antibody against rabies virus. It targets the viral envelope glycoprotein (G protein) of RABV and blocks its interaction with host receptors by binding to epitopes I and III. Through this mechanism, Silevimig Injection specifically neutralizes the RABV prior to the establishment of full protection by active rabies vaccination.
In a Phase III clinical trial in adults, the Product met its primary efficacy endpoint, demonstrating non-inferior protective efficacy compared with HRIG, the currently most used passive immunization product in China. The study confirmed that the Product provides immediate protection during the early stages of rabies virus exposure without compromising the active immune response induced by vaccination. In addition, a Phase III clinical trial in children and adolescents aged 2 to <18 years is currently ongoing in China. The Product has been granted a patent in China.
In September 2025, the Group through subsidiaries of the Company entered into an Exclusive Collaboration Agreement (the “Agreement”) with Chongqing Genrix Biopharmaceutical Co., Ltd.. In accordance with the Agreement, the Group has obtained exclusive commercialization rights for the Product in mainland China and exclusive licensing rights for the rest of the Asia-Pacific region, the Middle East and North Africa. The collaboration term extends until ten years after the Product receives the marketing approval in Mainland China (the “Initial Term for the Product”). Unless terminated or dissolved under the terms set forth in the Agreement, the Agreement will automatically renew for successive ten-year periods upon expiration of the Initial Term for the Product.
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
Reference:
1. Chinese Center for Disease Control and Prevention. Technical Guidelines for Human Rabies Prevention and Control (2016). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P020240906525420231910.pdf
2. Yin Wenwu, Wang Chuanlin, et al. Expert consensus on rabies exposure prophylaxis[J]. Chinese Journal of Preventive Medicine, 2019,53(7): 668-679. DOI:10.3760/cma.j.issn.0253-9624.2019.07.004
3. Chinese Center for Disease Control and Prevention. The National Regulation for the Rabies Exposure Prophylaxis (2023 Edition). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P020240906525421817465.pdf
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
June 15th, 2026 – TheNewswire - Muskoka Ontario – Steadright Critical Minerals Inc. (CSE: SCM) (“Steadright” or the “Company”), is pleased to update shareholders on the historic polymetallic Copper-Zinc-Lead-Silver-Gold Mine, known as the Goundafa Mine, which has a fully permitted Mining License. Steadright holds a Binding MOU on the site with $7.5 million USD remaining to purchase the shares of Ste Commerciale et Minière du Sahara(CMS) over the next 2.5 years. Steadright can accelerate payments through cash or common shares.
In April 2026 Steadright engaged Axiom Exploration Group Ltd. (“Axiom”), a global leader in integrated geoscience solutions, to support the rapid advancement of its diversified portfolio of high-potential critical mineral projects in Morocco. Axiom have recently been on site at the Goundafa Historic Minesite, after an unusual harsh winter.
Axiom has compiled and created a database of information from the Goundafa and was on site in May 2026 to geo-locate tailing piles as part of a contract signed for the sale of historic ‘Mineralized Stockpile’ with MoResCo Sarl for purchase of up to 14,400 metric tons. (See Press Release Dated: December 16th, 2025.) Samples were taken from shallow pits or sorted Mineralized piles. Photos were taken of each site, and samples and observations were recorded into the ESRI FieldMaps app (See Field Map May 2026 below). Samples were then sealed in bags along with a sample tag, and were in the custody of the authors through to delivery to Afrilab in Marrackech. Morocco.
Geochemical Analyses
All samples were prepared and analysed by African Laboratory for Mining and Environment (AfriLab), an ISO 9001-certified laboratory (Certificate No. MA20/819942595). Samples were crushed and pulverised to a nominal 85% passing 75 microns using standard mechanical preparation procedures (PRE.MO/ANA/015). Gold was analysed by Fire Assay with Atomic Absorption Spectrometry finish (FA-AAS) on a 50-gram charge (PRE.MO/ANA/001). Multi-element geochemistry was determined by Inductively Coupled Plasma (ICP) spectrometry following four-acid (HF-HNO₃-HClO₄-HCl) near-total digestion (PRE.MO/ANA/036). Follow-up on sampling to be reported.
Discussion
The site visit has helped a great deal to better understand the property for Axiom, with respect to the available reports. The state of the digital database continues to improve, even after the site visit, with additional digitisation of historical samples helping to visualise previous work and potential across the entire site.
Field Map Mineralized Tailing Piles Sampled at the Goundafa Mine Site May 2026
Sample Site 1, May 2026 picture
Goundafa Mine Site (Press Release Dated: December 16th, 2025)
“The Goundafa Mine was developed and mined by La Société des Mines de Goundafa (SMG) from the 1926 until 1956.Operations ceased due to political changes following Moroccan independence. A number of historical professional reports are available on the Goundafa Property. In 1928, two thousand tons with an average grade of 22.13% Zinc and 11.31% Lead were produced. In the 1985 report, "Rapport sur les travaux souterrains et la cartographieminiere de la concession de Goundafa” from the Bureau de Rescherches et de Participations Minières (BRPM), Morocco’s former national mining agency, now ONHYM, indicated Silver (Ag) grades of up to 400g/t from concentrate. As mining pursued deeper, increasing chalcopyrite and Gold (Au) content were observed. In total, historical production of 320k tons of material was reportedly extracted until 1956.
A 2022 geological report (non-NI 43-101 compliant), “Rapport Technique et Financier sur la Concession Minière de Goundafa – Commune d’Ijoukak, Province d’El Haouz, Maroc”, authored by Omar Guillou and prepared for CMS, the concession holder identified 6.62 Mt located above -300L and adjacent to old workings, but excludes exploration potential that is open along the strike and down dip of -300 L. The 2022 CMS report states: The historic “estimate is limited to the 600 vertical meters through accessible workings; are within a vertical interval of approximately 600 meters, between the surface and the deepest accessible workings”. However, the non-compliant tonnage estimate does not include “deeper speculative extensions”, and that “it could extend an additional 800 meters vertically, reaching depths of 1,400 meters below surface”. In addition, “the lateral extensions of Veins IV, V and Vi have been identified at surface through trenching and geological surveys. These extensions show structural continuity with the veins exploited at depth, but their potential remains to be confirmed by drilling. They are NOT INCLUDED in the main volumetric estimate of 6,620,000 Mt,although the project warrants drill testing to evaluate geological continuity and to collect data for potential future resource estimation.Existing adits, including mine workings, are available at the historic operations allowing easy access to the former mine.
The Goundafa Project is an early-stage polymetallic exploration project located in Morocco’s High Atlas Mountains — a region with a long mining history and favorable geology. The project is centered on a series of steeply dipping mineralized veins containing Lead, Zinc, Copper, Gold and Silver. These veins are exposed at surface and have seen limited artisanal mining since the French left, providing a strong foundation for modern exploration.
While the 2022 report for the CMS estimate does not meet the requirements of NI 43-101 and is not a formal mineral resource, it reflects the potential scale of the system with the convergence of multiple mineralized veins
Figure 11: Schematic of the Exploitation of the
Goundafa Deposit (Scale 1:2000)
The 2022 technical report was compiled and authored by Mr. Omar Guillou, who led the integration of historical data, field observations, and sampling results into a cohesive evaluation of the concession’s potential. Dr. Abdelaziz El Hadi, a senior structural geologist and academic researcher with over three decades of experience in Moroccan mineral systems, contributed to the geological interpretation and structural modeling. His work focused on vein geometry, structural stacking, and volumetric projections that informed the historical estimate. See Table 1 (Tableau 3) Historical Estimation of Insitu Tonnage by Vein (title modified) from the 2022 report and Table 2: Reconstructed Tons and Grade by Vein.
Follow up work on the Goundafa will continue as Steadright is committed to ensuring that a proper exploration is competed at the Goundafa Mine Site and looks forward to sharing further information as it pertains to the Mine Site and its potential.”
Steadright CEO, Matt Lewis, states, “The Moroccan teams are pressing hard to fulfill Steadright’s potential. I am very happy about the progress on the Goundafa, especially as it relates to the historic stockpiles we are contracted to sell.
We are looking over Axiom’s work at the Goundafa and will report back to the market shortly.
Morocco is an incredible country and we are very grateful for the opportunities afforded us by them.”
ABOUT STEADRIGHT CRITICAL MINERALS INC.
Steadright Critical Minerals Inc. is a mineral exploration company established in 2019. Steadright has been focused in 2025 on finding exploration and historical mining projects that can be brought into production within the Moroccan critical mineral space. Steadright currently has exposure through a Moroccan entity known as NSM Capital Sarl, with over 192 sq KMs of mineral exploration claims called the TitanBeach Titanium Project, along with the Copper Valey Project. Steadright has also has a binding MOU for the historic Goundafa Mine within the Kingdom of Morocco.
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking information is subject to known and unknown risks, uncertainties and other factors which may cause the actual results, level of activity, performance or achievements of Steadright to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: there is no certainty that the ongoing programs will result in significant or successful exploration and development of Steadright’s properties; uncertainty as to the actual results of exploration and development or operational activities; uncertainty as to the availability and terms of future financing on acceptable terms; uncertainty as to timely availability of permits and other governmental approvals; general business, economic, competitive, political and social uncertainties; capital market conditions and market prices for securities, junior market securities and mining exploration company securities; commodity prices; the actual results of current exploration and development or operational activities; competition; changes in project parameters as plans continue to be refined; accidents and other risks inherent in the mining industry; lack of insurance; delay or failure to receive board or regulatory approvals; changes in legislation, including environmental legislation or income tax legislation, affecting Steadright; conclusions of economic evaluations; and lack of qualified, skilled labour or loss of key individuals.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available.
April 28 (Reuters) - U.S. electric and gas utility CMS Energy (CMS.N), opens new tab on Tuesday beat Wall Street estimates for first-quarter profit and raised its capital expenditure plan on the back of rising power demand.
U.S. power companies are beefing up spending plans as the country's power demand is projected to rise, after decades of stagnation, driven by the growth of energy-intensive data centers.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
The utility now expects to spend about $24 billion in capital expenses through 2030, up from its prior view of $20 billion.
A recent electric rate order approved by the regulator granted roughly 66% of the company's requested hike.
Utilities have been seeking to raise customer power bills to fund infrastructure upgrades, as the country's electrical grids face growing demand from industry electrification and data-center expansions.
The Jackson, Michigan-based company earned $1.13 per share on an adjusted basis in the first quarter, compared with analysts' estimates of $1.10 per share, according to LSEG data.
CMS Energy's operating revenue rose 11.5% to $2.7 billion.
The utility reaffirmed its full-year profit forecast in the range of $3.83 to $3.90 per share.
Reporting by Pranav Mathur in Bengaluru; Editing by Vijay Kishore
Our Standards: The Thomson Reuters Trust Principles., opens new tab
CMS Energy (CMS) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.02 per share a year ago.
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.
Based in Jackson, CMS Energy (CMS - Free Report) is in the Utilities sector, and so far this year, shares have seen a price change of 8.57%. Currently paying a dividend of $0.57 per share, the company has a dividend yield of 3%. In comparison, the Utility - Electric Power industry's yield is 2.82%, while the S&P 500's yield is 1.39%.
Looking at dividend growth, the company's current annualized dividend of $2.28 is up 5.1% from last year. Over the last 5 years, CMS Energy has increased its dividend 5 times on a year-over-year basis for an average annual increase of 5.79%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. CMS Energy's current payout ratio is 60%, meaning it paid out 60% of its trailing 12-month EPS as dividend.
Looking at this fiscal year, CMS expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $3.87 per share, with earnings expected to increase 7.20% from the year ago period.
Investors like dividends for a variety of different reasons, from tax advantages and decreasing overall portfolio risk to considerably improving stock investing profits. It's important to keep in mind that not all companies provide a quarterly payout.
High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. That said, they can take comfort from the fact that CMS is not only an attractive dividend play, but also represents a compelling investment opportunity with a Zacks Rank of #2 (Buy).
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Board of Directors of Consumers Energy, the principal subsidiary of CMS Energy, has declared a quarterly dividend on the utility's preferred stock.
The following dividend is payable July 1, 2026, to shareholders of record at the close of business on June 1, 2026: $1.125 per share on the $4.50 preferred stock (NYSE: CMS_pb).
Additional dividend information, including the tax status of Consumers Energy's dividend distributions, can be obtained through the Tax Information section of CMS Energy's website.
CMS Energy (NYSE: CMS) is a Michigan-based energy provider featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
For more information on CMS Energy, please visit our website at cmsenergy.com.
To sign up for email alert notifications, please visit the Investor Relations section of our website.
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Board of Directors of CMS Energy has declared a dividend on the 4.200% Cumulative Redeemable Perpetual Preferred Stock, Series C of the Corporation.
The following dividend is payable July 15, 2026, to shareholders of record at the close of business on July 1, 2026: $0.2625 per depositary share (NYSE: CMS PRC).
Additional dividend information, including the tax status of CMS Energy's dividend distributions, can be obtained through the Tax Information section of CMS Energy's website.
CMS Energy (NYSE: CMS) is a Michigan-based energy provider featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
For more information on CMS Energy, please visit our website at cmsenergy.com.
To sign up for email alert notifications, please visit the Investor Relations section of our website.
Investors in CMS Energy Corporation (CMS - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $40.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for CMS Energy shares, but what is the fundamental picture for the company? Currently, CMS Energy is a Zacks Rank #3 (Hold) in the Utility - Electric Power industry that ranks in the Bottom 43% of our Zacks Industry Rank. Over the last 60 days, two analysts have increased their earnings estimates for the current quarter, while none have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from 64 cents per share to 68 cents in that period.
Given the way analysts feel about CMS Energy right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
A month has gone by since the last earnings report for CMS Energy (CMS - Free Report) . Shares have lost about 0.7% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is CMS Energy due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.
CMS Energy Q1 Earnings Beat Estimates, Revenues Increase Y/Y
CMS Energy Corporation reported first-quarter 2026 earnings per share (EPS) of $1.13, which beat the Zacks Consensus Estimate of $1.11 by 1.8%. The bottom line also increased 10.8% from $1.02 in the prior-year quarter.
The company reported GAAP earnings of $1.10 per share, up from $1.01 recorded in the year-ago quarter.
CMS' RevenuesOperating revenues totaled $2.73 billion, which topped the Zacks Consensus Estimate of $2.53 billion by 8.1%. The top line also increased 11.6% from $2.45 billion in the prior-year quarter.
Operational Performance of CMSCMS' operating expenses amounted to $2.24 billion, up 14.7% from the year-ago quarter’s figure.
Operating income was $490 million, lower than the year-ago quarter’s figure of $494 million.
Interest charges totaled $203 million, up 9.1% from that recorded in the year-ago quarter.
Financial Condition of CMSCMS Energy had cash and cash equivalents of $175 million as of March 31, 2026 compared with $509 million as of Dec. 31, 2025.
As of March 31, 2026, total debt and financial leases (excluding securitization debt) were $18.54 billion compared with $18.31 billion as of Dec. 31, 2025.
The net cash flow from operating activities was $0.71 billion during the first three months of 2026 compared with $1 billion in the prior-year period.
CMS' 2026 GuidanceThe company reaffirmed its 2026 adjusted earnings guidance of $3.83-$3.90 per share. The Zacks Consensus Estimate for 2026 earnings is currently pegged at $3.87, higher than the midpoint of the company’s guided range.
CMS also reaffirmed its long-term adjusted EPS growth in the band of 6-8%.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates revision.
VGM ScoresAt this time, CMS Energy has a poor Growth Score of F, a score with the same score on the momentum front. However, the stock was allocated a grade of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Interestingly, CMS Energy has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
MCLEAN, Va., June 01, 2026 (GLOBE NEWSWIRE) -- To kick off a month-long celebration of the 15-year anniversary of its founding, the Thought Leadership & Innovation Foundation (TLI) today announced the release of its new whitepaper, The Medicare Advantage Final Rule: A Defining Moment for O&P—and Why Data Will Decide Who Wins, alongside the pilot launch of the Limb Outcomes Voice (LOV), a new patient-centered outcomes platform designed to elevate the voice of individuals living with limb loss and limb difference.
Together, these initiatives represent a coordinated effort to help the orthotics and prosthetics (O&P) industry prepare for the accelerating shift toward value-based healthcare and outcomes-driven reimbursement.
The newly released whitepaper examines how the CMS Medicare Advantage Final Rule signals a broader transformation in healthcare policy—one that increasingly ties reimbursement, network participation, and provider value to measurable clinical outcomes and patient impact.
“The industry is entering a new environment where value can no longer simply be described—it must be demonstrated,” said Bill Oldham, Founder of the Thought Leadership & Innovation Foundation. “Outcomes data and patient-reported experiences are becoming essential infrastructure for the future of O&P.”
Central to the whitepaper is the growing importance of the Limb Loss and Preservation Registry (LLPR), which enables providers and researchers to systematically capture longitudinal outcomes data across the limb loss and limb preservation population.
At the same time, TLI is launching the pilot phase of Limb Outcomes Voice (LOV), a patient engagement and reporting platform designed to give individuals living with limb loss and limb difference direct access to meaningful insights about their mobility, function, quality of life, and health outcomes.
LOV allows participants to:
Complete outcomes surveys and assessmentsView personalized reports and benchmark insightsAccess educational resources and support organizationsContribute their voice to a larger national outcomes effort According to TLI, the connection between the CMS Final Rule, LLPR, and LOV is intentional.
“The future of healthcare will increasingly be shaped by real-world outcomes and patient experience,” Oldham said. “LOV helps ensure that the patient voice becomes part of the data infrastructure informing clinical care, policy decisions, and reimbursement models.”
The organization believes the combination of provider-driven registry data through LLPR and patient-reported insights through LOV creates a more complete picture of outcomes across the O&P continuum of care.
The whitepaper calls on O&P providers, manufacturers, researchers, and advocacy organizations to work collaboratively to strengthen outcomes measurement, improve data transparency, and ensure the profession plays an active role in defining how value is measured in the future healthcare landscape.
About the Thought Leadership & Innovation Foundation
The Thought Leadership & Innovation Foundation (TLI) is a nonprofit organization focused on advancing innovation, collaboration, and data-driven transformation across healthcare and rehabilitation. Through strategic initiatives, research partnerships, and technology-enabled platforms, TLI works to improve patient outcomes and strengthen the future of care for individuals living with limb loss and limb difference.
For more information, visit:
www.thoughtfoundation.org
Media Contact:
Thought Leadership & Innovation Foundation [email protected]
, /PRNewswire/ -- CMS Energy announced today, Sri Maddipati, currently Consumers Energy's senior vice president and president of electric supply, will be named CMS Energy and Consumers Energy Executive Vice President and Chief Financial Officer, effective on June 3. Sri will oversee Investor Relations, Treasury, Tax, Accounting, and Financial Planning. Chris Fultz, vice president of low voltage distribution at Consumers Energy, will become the new senior vice president and president of electric supply, also effective on June 3. Chris will manage the company's electric supply business unit, which includes electric supply planning and strategy, market operations, generating plant operations and engineering, generation development and procurement.
"Sri has nearly 20 years of experience across finance, treasury, banking, capital markets, and investor relations which allows for a seamless transition of leadership," said Garrick Rochow, President and CEO of CMS Energy and Consumers Energy. "Sri has held several senior leadership positions across our company and brings a combination of financial, operational, strategic and regulatory skills which reflects the company's thoughtful approach to development and succession and makes him exceptionally well-suited to serve as our next CFO and help lead the company forward."
Sri joined CMS Energy in 2014 and was elected as vice president and treasurer in 2016 where he was responsible for budget and planning, corporate liquidity, financing and maintaining relationships with investors, banks and rating agencies, a position he held until he moved to the role of Consumers Energy vice president electric supply in 2023. In that role, Sri was responsible for Consumers Energy's electric supply business unit, which includes electric supply planning and strategy, market operations, generating plant operations and engineering, and generation development and procurement. Sri was appointed Consumers Energy senior vice president and president of the electric supply business unit in 2025. Prior to joining CMS Energy, Sri was a vice president in the financial institutions group at Goldman Sachs. Sri holds bachelor's and master's degrees in engineering and a Master in Business Administration, all from the University of Michigan.
"Chris brings a clear commitment to safety, reliability, and affordability, along with the ability to lead large-scale operations and teams to the electric supply organization," said Garrick Rochow, President and CEO of CMS Energy and Consumers Energy. "His broad expertise and leadership within operations, engineering, and project management will be an asset as we plan and execute our long-term energy supply blueprint."
Chris previously served as vice president of low voltage distribution in our electric business and vice president of natural gas operations. Since joining the company in 2014, Chris held increasingly responsible roles within project management, natural gas operations, transmission, storage and compression. Prior to Consumers Energy, Fultz worked for Black & Veatch, and he holds bachelor's and master's degrees in electrical engineering from Michigan Technological University, and a master's degree in business administration from Oakland University.
Rejji Hayes will retire as Executive Vice President and Chief Financial Officer, effective June 3.
"I want to thank Rejji Hayes for his leadership and many contributions to the company. His impact to our co-workers, communities, customers, and investors has been meaningful, and we are grateful for his service. I wish Rejji the very best in the future."
CMS Energy (NYSE: CMS) is a Michigan-based energy provider featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
Investors and others should note that CMS Energy routinely posts important information on its website and considers the Investor Relations section, www.cmsenergy.com/investor-relations, a channel of distribution.
, /PRNewswire/ -- CMS Energy announced today, Sri Maddipati, currently Consumers Energy's senior vice president and president of electric supply, will be named CMS Energy and Consumers Energy Executive Vice President and Chief Financial Officer, effective on June 3. Sri will oversee Investor Relations, Treasury, Tax, Accounting, and Financial Planning. Chris Fultz, vice president of low voltage distribution at Consumers Energy, will become the new senior vice president and president of electric supply, also effective on June 3. Chris will manage the company's electric supply business unit, which includes electric supply planning and strategy, market operations, generating plant operations and engineering, generation development and procurement.
"Sri has nearly 20 years of experience across finance, treasury, banking, capital markets, and investor relations which allows for a seamless transition of leadership," said Garrick Rochow, President and CEO of CMS Energy and Consumers Energy. "Sri has held several senior leadership positions across our company and brings a combination of financial, operational, strategic and regulatory skills which reflects the company's thoughtful approach to development and succession and makes him exceptionally well-suited to serve as our next CFO and help lead the company forward."
Sri joined CMS Energy in 2014 and was elected as vice president and treasurer in 2016 where he was responsible for budget and planning, corporate liquidity, financing and maintaining relationships with investors, banks and rating agencies, a position he held until he moved to the role of Consumers Energy vice president electric supply in 2023. In that role, Sri was responsible for Consumers Energy's electric supply business unit, which includes electric supply planning and strategy, market operations, generating plant operations and engineering, and generation development and procurement. Sri was appointed Consumers Energy senior vice president and president of the electric supply business unit in 2025. Prior to joining CMS Energy, Sri was a vice president in the financial institutions group at Goldman Sachs. Sri holds bachelor's and master's degrees in engineering and a Master in Business Administration, all from the University of Michigan.
"Chris brings a clear commitment to safety, reliability, and affordability, along with the ability to lead large-scale operations and teams to the electric supply organization," said Garrick Rochow, President and CEO of CMS Energy and Consumers Energy. "His broad expertise and leadership within operations, engineering, and project management will be an asset as we plan and execute our long-term energy supply blueprint."
Chris previously served as vice president of low voltage distribution in our electric business and vice president of natural gas operations. Since joining the company in 2014, Chris held increasingly responsible roles within project management, natural gas operations, transmission, storage and compression. Prior to Consumers Energy, Fultz worked for Black & Veatch, and he holds bachelor's and master's degrees in electrical engineering from Michigan Technological University, and a master's degree in business administration from Oakland University.
Rejji Hayes will retire as Executive Vice President and Chief Financial Officer, effective June 3.
"I want to thank Rejji Hayes for his leadership and many contributions to the company. His impact to our co-workers, communities, customers, and investors has been meaningful, and we are grateful for his service. I wish Rejji the very best in the future."
CMS Energy (NYSE: CMS) is a Michigan-based energy provider featuring Consumers Energy as its primary business. It also owns and operates independent power generation businesses.
Investors and others should note that CMS Energy routinely posts important information on its website and considers the Investor Relations section, www.cmsenergy.com/investor-relations, a channel of distribution.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cms-energy-announces-sri-maddipati-as-chief-financial-officer-chris-fultz-as-president-of-electric-supply-302790426.html
CMS Energy is an American energy holding company. Founded in 1886, CMS is now a $22 billion (by market cap) energy player employing more than 8,000 people. CMS has increased its dividend for 20 consecutive years. Its 10-year dividend growth rate of 6.5% is very solid for a power utility. CMS has a fairly standard financial position for a power utility. Its long-term debt/equity ratio is 1.8, while the interest coverage ratio is over 2.
Clover stock is at critical resistance. What’s behind CLOV new highs? The Legal WinOn June 9, CMS informed Clover that it had recalculated the rating to 4.5 Stars and instructed the company to submit alternate bids at that level. The upgraded rating applies to Clover’s PPO plan, Contract H5141, which covers more than 97% of the company’s members. Clover’s HMO plan’s 2026 Star Rating was not subject to the litigation and remains at 4.0 Stars.
Why It MattersThe Star Rating upgrade is significant because Medicare Star Ratings directly impact the reimbursement rates Clover receives from CMS for Payment Year 2027. A jump from 3.5 to 4.5 Stars means meaningfully higher payments from the government — improving the company’s revenue outlook at a time when it is targeting its first-ever full year of net income profitability in 2026.
Clover Shares SurgeCLOV Price Action: At the time of publication, Clover shares are trading 4.29% higher at $5.10, according to data from Benzinga Pro.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
